Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study

J Antimicrob Chemother. 1997 Sep;40(3):449-52. doi: 10.1093/jac/40.3.449.

Abstract

Seven cases of enterococcal endocarditis treated with teicoplanin (7-10 mg/kg/day for 28-105 days) alone (one case) or in combination with aminoglycosides (six cases) were reviewed. All patients were cured. Serum bactericidal activity titres after intravenous gentamicin (5 mg/kg every 24 h) and teicoplanin (10 mg/kg every 24 h) were measured on day 7 of treatment in four patients against five enterococcal isolates: mean titres were 1:54 (range 1:16-64) and 1:22 (1:8-32) at 0.5 and 24 h post-infusion, respectively. Time-kill studies showed synergy between teicoplanin and gentamicin against three isolates. We conclude that single daily-dose teicoplanin/gentamicin combined therapy may represent a rational alternative to standard penicillin/gentamicin therapy and a useful regimen for home treatment of selected cases of enterococcal endocarditis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Blood Bactericidal Activity
  • Drug Therapy, Combination / therapeutic use
  • Endocarditis, Bacterial / drug therapy*
  • Gentamicins / therapeutic use
  • Gram-Positive Bacterial Infections / drug therapy*
  • Humans
  • Middle Aged
  • Teicoplanin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Teicoplanin